Back to Search Start Over

180-degree immersive VR motion visualization in the treatment of haemophilic ankle arthropathy

Authors :
Roberto Ucero‐Lozano
Raúl Pérez‐Llanes
José Antonio López‐Pina
Rubén Cuesta‐Barriuso
Source :
Scopus
Publication Year :
2022

Abstract

Background Patients with haemophilic arthropathy suffer chronic pain that affects and restricts their quality of life. Visualization of movement through immersive virtual reality is used for pain management. Aim To evaluate the efficacy of 180-degree immersive VR motion visualization therapy in patients with haemophilic ankle arthropathy. Methods Prospective, multicentre pilot study. Fifteen adult patients with bilateral haemophilic ankle arthropathy were recruited (mean age: 42.73 ± 12.36 years). The intervention lasted 4 weeks, with daily home sessions of 180-degree immersive motion visualization. The patients were given virtual reality glasses to use with their smartphones. From the YouTube mobile app® they accessed the recorded video with access from the He-Mirror App®. The study variables were joint state (Haemophilia Joint Health Score), pressure pain threshold (pressure algometer), muscle strength (dynamometry) and range of motion (goniometry). Three evaluations were performed: at baseline (T0), after the intervention (T1) and at the end of a 16-week follow-up period (T2). Results No patient developed ankle hemarthrosis during the experimental phase. In the repeated measures analysis we found statistically significant differences in joint state (F = 51.38; η2p = .63), pressure pain threshold of the lateral malleolus (F = 12.34; η2p = .29) and range of motion (F = 11.7; η2p = .28). Conclusions Therapy using immersive motion visualization does not cause hemarthrosis. This intervention can improve joint condition, pressure pain threshold and range of motion in patients with ankle arthropathy. Changes greater than the MDC were reported in more than 40% of patients for the variables pressure pain threshold, anterior tibialis strength and range of motion, which were considered clinically relevant. Sin financiación 4.268 JCR (2021) Q2, 34/78 Hematology 1.449 SJR (2021) Q1, 19/96 Genetics (clinical) No data IDR 2021 UEM

Details

Language :
English
Database :
OpenAIRE
Journal :
Scopus
Accession number :
edsair.doi.dedup.....22acdbb4327171e03191b465a86e9937